Asset Management One Co., Ltd. Ultragenyx Pharmaceutical Inc. Transaction History

Asset Management One Co., Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$72.98 - $90.0 $355,631 - $438,570	-4,873 Reduced 26.79%	13,314 $1.09 Million
Q2 2019 Aug 14, 2019	SELL	$54.93 - $74.36 $1.01 Million - $1.37 Million	-18,449 Reduced 50.36%	18,187 $1.16 Million
Q1 2019 May 15, 2019	BUY	$39.87 - $69.36 $227,498 - $395,768	5,706 Added 18.45%	36,636 $2.54 Million
Q4 2018 Feb 13, 2019	SELL	$38.89 - $77.3 $16,372 - $32,543	-421 Reduced 1.34%	30,930 $1.3 Million
Q3 2018 Nov 14, 2018	SELL	$71.81 - $90.15 $501,377 - $629,427	-6,982 Reduced 18.21%	31,351 $2.5 Million
Q2 2018 Aug 14, 2018	SELL	$48.54 - $85.31 $495,399 - $870,673	-10,206 Reduced 21.03%	38,333 $2.92 Million
Q2 2017 Aug 14, 2017	BUY	N/A	48,539	48,539 $3 Million

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Asset Management One Co., Ltd. with notifications on news.